Outpatient hybrid intracavitary-interstitial brachytherapy for cervical cancer with minimal sedation in a freestanding setting
High-dose-rate, image-guided adaptive hybrid brachytherapy boost with minimal sedation is feasible in the freestanding clinic setting, with a high percentage of patients completing treatment (96.8 %). Twenty-two percent (22.1 %) of patients had vaginal bleeding, all resolved with vaginal packing and pressure. Combining intracavitary and interstitial implants using a hybrid applicator appears to be feasible, efficient and safe in an outpatient freestanding clinic. Further studies are warranted.
Authors
- Ngoc‐Anh Le (ORCID: https://orcid.org/0000-0002-2634-4798)
- Lyndsay Willmott (ORCID: https://orcid.org/0009-0007-8004-2559)
- Shyamal Patel (ORCID: https://orcid.org/0000-0002-4969-3317)
- Alwin Issac (ORCID: https://orcid.org/0000-0002-4528-8787)
- Kavin Mutyala
- Bhuvi Mamtani
Institutions
- Creighton University (US)
- University of Arizona (US)
- University of Phoenix (US)
- Paradise Valley Community College (US)
- Dignity Health (US)
- Academy of Arts (EG)
- Arizona Research Center (US)
- Arizona Oncology (US)
- Phoenix College (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-05-18
- DOI
- https://doi.org/10.1016/j.gore.2025.101767
- Citations
- 2
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.11